Will Netflix remain the king of all streaming, or will Disney topple the upstart?
It might morph into an incredibly valuable financial services company, or even a super-bank.
The stock market is severely underpricing a gaming stock for your smart phone and a speed-boat manufacturer.
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
This tiny biotech has a long history of failure, but it also has a flu vaccine that is likely to be approved by the FDA.
Microsoft has a flaw, and tiny Smartsheet is taking advantage of it.
This French video-game company's stock has taken a big hit, but we like what it has in store.
It's highly likely that Immunomedics' billion-dollar drug will finally be approved by the FDA.
An online startup is disrupting an industry with a cheaper and easier alternative.
It's an amazing company with fantastic revenue growth. But there's one small problem that's keeping me on the sidelines.
When it comes to investing in IPOs like Beyond Meat safely, don't forget to factor in the Unlocking of the Shares.
A great company just went on sale.
The payments business is being invaded from Down Under by a company that wants you to afterpay your big purchases.
Wall Street hated the New Guards acquisition. But maybe the fashion industry knows something the Street is missing.
The stock of Vir Biotechnology lost 30% of its value on its first day of trading.
These companies' collaborations with bigger businesses validates their science -- and paves the way for future revenues and profits.
An internet retailer is in the midst of disrupting a massive industry, and it's happening right before our eyes.
A picks-and-shovels play and a Permian Basin pipe operator are energetic picks in a volatile space.
Amarin's Vascepa just might be a blockbuster.
Ionis Pharma has some powerful numbers now. But its future opportunities are even more amazing.